The Effectiveness of Using Interferon-gamma Release Assays in Screening Immigration Employees for Latent Tuberculosis Infection

References

• Styblo K. Recent advances in epidemiological research in tuberculosis. Adv Tuberc Res. 1980; 20: 1–63.
   PubMedGoogle Scholar
• Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. JAMA. 1999; 282 (7): 677–686.
   Google Scholar
• Jasmer RM, Nahid P, Hopwell PC. Clinical practice. Latent tuberculosis infection. N Engl J Med. 2002; 347 (23): 1860–1866.
   PubMed Web of Science ®Google Scholar
• Stewart GR, Robertson BD, Young DB. Tuberculosis: A problem with persistence. Nat Rev Microbiol. 2003; 1: 97–105.
   PubMed Web of Science ®Google Scholar
• Vynnycky E, Fine PE. Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol. 2000; 152: 247–63.
   PubMed Web of Science ®Google Scholar
• U.S. Census Bureau. American Community Survey. 2009. http: //www.census.gov/acs/www. Date accessed: September 2010.
   Google Scholar
• Centers for Disease Control and Prevention. Decrease in reported tuberculosis cases—United States, 2009. MMWR. 2010; 59 (RR-10): 289–294.
   Google Scholar
• Schneider DL, Lobato MN. Tuberculosis control among people in U.S. Immigration and Customs Enforcement custody. Am J Prey Med. 2007; 3 (1): 9–14.
   Google Scholar
• Centers for Disease Control and Prevention. Guidelines for theinvestigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC. MMWR. 2005;54(RR-15):1–47.
   Google Scholar
• Centers for Disease Control and Prevention. Prevention and control of tuberculosis in correctional and detention facilities: Recommendations from CDC. MMWR. 2006;55(RR-9):1–48.
   Google Scholar
• Huebner RE, Schein MF, Bass JBJr. The tuberculin skin test. Clin Infect Dis. 1993; 17: 968–975.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society, Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161 (4): S221–47.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med. 2000; 161 (4): 1376–1395.
   Google Scholar
• Pai M, Riley LW, Colford JMJr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review. Lancet Infect Dis. 2004; 4 (12): 761–767.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR. 2010;59(RR-5):10.
   Google Scholar
• Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet. 2000; 356 (9235): 1099–1104.
   PubMed Web of Science ®Google Scholar
• Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med. 2004; 170 (1): 59–64.
   PubMed Web of Science ®Google Scholar
• Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Intern Med. 2007; 146 (5): 340–344.
   PubMed Web of Science ®Google Scholar
• Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med. 2008; 149 (3): 177–184.
   PubMed Web of Science ®Google Scholar
• National Institute for Occupational Safety and Health. Health hazard evaluation report: evaluation of exposure to tuberculosis among immigration employees. Broadview and Chicago, IL. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, NIOSH BETA No. 2009-0074; 2009-0193-3114.
   Google Scholar
• Cain KP, Benoit SR, Winston CA, MacKenzie WR. Tuberculosis among foreign-born persons in the United States. JAMA. 2008; 300 (4): 405–412.
   PubMed Web of Science ®Google Scholar
• Achkar JM, Sherpa T, Cohen HW, Holzman RS. Differences in clinical presentation among persons with pulmonary tuberculosis: A comparison of documented and undocumented foreign-born versus U.S.-born persons. Clin Infect Dis. 2008;47 (10): 1277–83.
   Google Scholar
• de Perio MA, Tsevat J, Roselle GA, Kralovic SM, Eckman MH. Cost-effectiveness of interferon gamma release assays vs. tuber-culin skin tests in health care workers. Arch Intern Med. 2009; 169 (2): 179–187.
   Google Scholar
• Diel R, Wrighton-Smith P, Zellweger JP. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis. Eur Respir J. 2007; 30 (2): 321–332.
   PubMed Web of Science ®Google Scholar
• Kowada A, Takahashi O, Shimbo T, Ohde S, Tokuda Y, Fukui T. Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan. Mol Diagn Then 2008;12 (4): 235–51.
   PubMed Web of Science ®Google Scholar
• Mazurek GH, Dajdowiicz MJ, Hankinson AL, et al. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-? release assays. Clin Infect Dis. 2007; 45 (1): 826–836.
   PubMedGoogle Scholar
• Cummings KJ, Smith TS, Shogren ES, et al. Prospective comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube assay for the detection of latent tuberculosis infection among healthcare workers in a low-incidence setting. Infect Control Hosp Epidemiol. 2009; 30 (11): 1123–1126.
   PubMed Web of Science ®Google Scholar
• Rattner SL, Fleischer JA, Davidson BL. Tuberculin positivity and patient contact in healthcare workers in the urban United States. Infect Control Hosp Epidemiol. 1996; 17 (6): 369–371.
   PubMed Web of Science ®Google Scholar
• Ball R, Van Wey M. Tuberculosis skin test conversion among health care workers at a military medical center. Mil Med. 1997; 162 (5): 338–343.
   PubMed Web of Science ®Google Scholar
• Hallak KM, Schenk M, Neale AV. Evaluation of the two-step tuberculin skin test in health care workers at an inner-city medical center. J Occup Environ Med. 1999; 41 (5): 393–396.
   PubMed Web of Science ®Google Scholar
• Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GA. Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr Opin Pulm Med. 2005; 11 (3)195–202.
   Google Scholar
• Pai M, Dheda K, Cunningham J, Scano F, O'Brien R. T-cell assays for the diagnosis of latent tuberculosis infection: Moving the research agenda forward. Lancet Infect Dis. 2007; 7: 428–438.
   PubMed Web of Science ®Google Scholar
• Choi JC, Shin JW, Kim JY, et al. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection. Chest. 2008; 133: 1415–20.
   PubMed Web of Science ®Google Scholar
• Ewer K, Millington KA, Deeks JJ, et al. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2006; 174: 831–9.
   PubMed Web of Science ®Google Scholar
• Hill PC, Brookes RH, Fox A, et al. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med. 2007; 4: e192.
   PubMed Web of Science ®Google Scholar
• Hill PC, Jeffries DJ, Brookes RH, et al. Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts. PLoS ONE. 2007; 2: e183.
   PubMedGoogle Scholar
• Igari H, Watanabe A, Sato T. Booster phenomenon of Quanti-FERON-TB Gold after prior intradermal PPD injection. Int J Tuberc Lung Dis. 2007; 11: 788–91.
   PubMed Web of Science ®Google Scholar
• Naseer A, Naqvi S, Kampmann B. Evidence for boosting Mycobacterium tuberculosis-specific IFN-gamma responses at 6 weeks following tuberculin skin testing. Eur Respir J. 2007; 29: 1282-83.
   Google Scholar
• Perry S, Sanchez L, Yang S, et al. Reproducibility of Quanti-FERON-TB gold in-tube assay. Clin Vaccine Immunol. 2008; 15: 425–32.
   PubMedGoogle Scholar
• Veerapathran A, Joshi R, Goswami K, et al. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS ONE. 2008; 3: e1850.
   PubMedGoogle Scholar
• Torres Costa J, Silva R, Sá R, Cardoso MJ, Nienhaus A. Serial testing with the interferon-gamma release assay in Portuguese healthcare workers. Int Arch Occup Environ Health. 2010 Aug 19 [Epub ahead of print].
   Google Scholar